ID: ALA4445713

Max Phase: Preclinical

Molecular Formula: C27H18N2O3

Molecular Weight: 418.45

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)OC1=C(c2cnc3ccccc3c2)Oc2cc3ccccc3cc2-n2cccc21

Standard InChI:  InChI=1S/C27H18N2O3/c1-17(30)31-27-23-11-6-12-29(23)24-14-18-7-2-3-8-19(18)15-25(24)32-26(27)21-13-20-9-4-5-10-22(20)28-16-21/h2-16H,1H3

Standard InChI Key:  KBEHTEGCAHJHQJ-UHFFFAOYSA-N

Associated Targets(Human)

HL-60 67320 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PC-9 1037 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCC827 1172 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 4610 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

B16-F1 104 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 418.45Molecular Weight (Monoisotopic): 418.1317AlogP: 5.96#Rotatable Bonds: 2
Polar Surface Area: 53.35Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.45CX LogP: 4.58CX LogD: 4.58
Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.33Np Likeness Score: -0.18

References

1. Brindisi M, Ulivieri C, Alfano G, Gemma S, de Asís Balaguer F, Khan T, Grillo A, Chemi G, Menchon G, Prota AE, Olieric N, Lucena-Agell D, Barasoain I, Diaz JF, Nebbioso A, Conte M, Lopresti L, Magnano S, Amet R, Kinsella P, Zisterer DM, Ibrahim O, O'Sullivan J, Morbidelli L, Spaccapelo R, Baldari C, Butini S, Novellino E, Campiani G, Altucci L, Steinmetz MO, Brogi S..  (2019)  Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents.,  162  [PMID:30448418] [10.1016/j.ejmech.2018.11.004]

Source